News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
April, 2025
April 2025
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
Interim results from the EUROPA trial presented at SABCS24 – The Lancet Oncology
Icro Meattini/X
Dec 13, 2024, 19:52

Interim results from the EUROPA trial presented at SABCS24 – The Lancet Oncology

The Lancet Oncology shared a recent article on X:

“Presented at SABCS24: Interim results from the EUROPA trial: Single-modality endocrine therapy vs radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal a-like early breast cancer.”

Title: Single-modality endocrine therapy versus radiotherapy after breast-conserving surgery in women aged 70 years and older with luminal A-like early breast cancer (EUROPA): a preplanned interim analysis of a phase 3, non-inferiority, randomised trial

Authors: Icro Meattini, Maria Carmen De Santis, Luca Visani, Marta Scorsetti, Alessandra Fozza, Bruno Meduri, Fiorenza De Rose, Elisabetta Bonzano, Agnese Prisco, Valeria Masiello, Eliana La Rocca, Ruggero Spoto, Carlotta Becherini, Gladys Blandino, Luca Moscetti, Riccardo Ray Colciago, Riccardo A Audisio, Etienne Brain, Saverio Caini, Marije Hamaker, Orit Kaidar-Person, Matteo Lambertini, Livia Marrazzo, Calogero Saieva, Tanja Spanic, Vratislav Strnad, Sally Wheelwright, Philip M P Poortmans and Lorenzo Livi

The Lancet Oncology

More posts featuring The Lancet Oncology.

Breast Cancer breast conserving surgery cancer endocrine endocrine therapy EUROPA trial Icro Meattini Lorenzo Livi Luca Visani Maria Carmen De Santis Marta Scorsetti OncoDaily Oncology Philip M P Poortmans radiotherapy SABCS24 Sally Wheelwright The Lancet Oncology
Special Coverage
Blog
Apr 15, 2025, 12:08
Luis Lara-Mejía: Oncogenic fusions represent a diagnostic challenge across solid tumors
Blog
Apr 15, 2025, 12:02
Early registration is closing for the ESMO Gynaecological Cancers 2025
Blog
Apr 15, 2025, 11:54
Esosa Omoregie: Day 2 at ASBMB 2025 - Insights, networking, and career growth
Blog
Apr 15, 2025, 11:52
Diego A. Díaz García: Updates on the treatment of EGFR-mutant NSCLC
Career
Apr 15, 2025, 11:46
Merel Hennink has been appointed to the Board of Lung Cancer Europe
Oncolibrary
Apr 15, 2025, 11:34
New Paper Alert: Insights from the PALMARES-2 Study: Improved Outcomes with Abemaciclib and Ribociclib in HR+/HER2- ABC
Blog
Apr 15, 2025, 11:34
Insightful updates and lively discussions at the EUonQoL General Assembly - European Cancer Organisation
Blog
Apr 15, 2025, 11:30
Moshe Ornstein as the moderator for KidneyCAN's upcoming Town Hall
Blog
Apr 15, 2025, 11:20
Support cancer research that creates better treatments for pediatric cancer patients - NFCR
Insight
Apr 15, 2025, 11:00
Roberto Vasquez Sheds Light on LMICs' Struggles with Cancer Drug Access
Blog
Apr 15, 2025, 10:52
The first lectures of the Masterclass on Gynecopathology by Matias-Guiu - European Society of Pathology
Insight
Apr 15, 2025, 10:23
Anna Avagyan on Armenia's ACT4Children Program and Genetic Risk Clinics